Press Releases

New Gateway Genomics Publication Shows SneakPeek Early Gender DNA Blood Test Accurately Identifies Fetal Sex at 7 Weeks into Pregnancy

In a large-scale study across 12 independent clinics, correct fetal sex results were provided for 125 out of 125 women at 7 weeks gestational age.

Gateway Genomics, leading provider of direct-to-consumer genetic tests focused on prenatal and pediatric information, announces a new publication titled, “Accurate Fetal Sex Determination from Maternal Blood at 7 Weeks Gestation” in the Journal of Pregnancy & Child Health. In the study, DNA blood samples were collected from 125 women at 7 weeks gestation across 12 independent clinics in the United States. Cell-free fetal DNA (cffDNA) was extracted and run through the SneakPeek test process, which looks for male chromosomes.

read more

Gateway Genomics Earns Prestigious Mom’s Choice Award for SneakPeek Early Gender DNA Test as One of the Best Products for Families

An independent review panel received SneakPeek Gender test kits to evaluate, use, and score on elements including educational value, design, production quality, and cost.

Gateway Genomics, a leading developer of direct-to-consumer genetic tests that give families insight into their future children, announces that the Mom’s Choice Award Among the Best in Family-Friendly Products was awarded to SneakPeek Gender DNA Test. To be considered for the award, five SneakPeek Gender DNA At-Home test kits were submitted for use to Mom’s Choice, which matched the products with appropriate evaluators in the MCA database.

read more

Gateway Genomics Ranks 601 in the Inc. 5000 Fastest-Growing Private Companies in America List for 2021

For the third year in a row, Gateway Genomics was one of the fastest-growing private companies in the Health sector, which includes biotech, pharmaceutical firms, and makers of medical devices and products for the health care market.

Gateway Genomics, a leading developer of direct-to-consumer genetic tests that give families insight into their future children, announces inclusion in the Inc. 5000 2021 list of fastest growing private companies for the third straight year. To qualify, companies must have been founded and generating revenue by March 31, 2017. Ranking in the list is determined by the percentage revenue growth from 2017 to 2020, with minimums set for each year.

read more

Gateway Genomics Launches the SneakPeek Brand Affiliates Program to Build Community for Fetal Sex Detection

SneakPeek Early Gender DNA Test lets parents learn the sex of their baby at 8 weeks into pregnancy with 99.9% accuracy.

Gateway Genomics, market leader of direct-to-consumer genetic tests focused on prenatal and pediatric information, announces the launch of the new SneakPeek Brand Affiliates program that allows partners and supporters to promote SneakPeek Gender or Traits At-home products and receive a commission.

read more

Gateway Genomics Launches the Breakthrough SneakPeek Snap Which Eliminates Need for Fingerstick Blood Collection from Fetal Sex Testing

SneakPeek Snap is the first and only push-button, microneedle-based device available for parents to learn the gender of their babies, months earlier than ultrasound.

Gateway Genomics, leading provider of direct-to-consumer genetic tests focused on prenatal and pediatric information, announces the launch of the new SneakPeek Snap. SneakPeek Snap is a self-administered device that collects capillary blood through the upper arm rather than the sensitive fingertip, thereby reducing pain from 78% to 10% as noted in a recent clinical study. The automated, self-contained nature of SneakPeek Snap also made it easier to use, reducing difficulty from 60% to 10%.

read more

Gateway Genomics Publication Shows Breakthrough SneakPeek Snap Microneedle-based Device to be Virtually Painless

In the clinical study, 90% of participants found SneakPeek Snap to cause no pain, versus only 22% using the traditional lancet device for blood collection.

Gateway Genomics, leading provider of direct-to-consumer genetic tests focused on prenatal and pediatric information, announces a new publication titled, “SneakPeek Snap: A Painless Microneedle-Based Push-Button Device for Early Fetal Sex Determination” in the International Journal of Pregnancy & Child Birth.

read more

Gateway Genomics Ranks No. 56 in the Inc. 5000 Series: California’s Fastest-Growing Private Companies for 2021

For the second straight year, Gateway Genomics ranks as one of the top private companies in the Health sector, which includes biotech, pharmaceutical firms, and makers of medical devise and products for the health care market.

Gateway Genomics, a leading developer of direct-to-consumer genetic tests that give families insight into their future children, was recognized in this year’s Inc. 5000’s California list for the second year in a row, emerging as the 56th fastest-growing private company in the state, and #6 in the Health sector. Last year the company was included in the 2020 annual Inc. 5000 list of fastest-growing private companies in the United States.

read more

Gateway Genomics Surpasses 1000 Clinical Locations Across the US, UK, and Canada

Attracted by the ability to acquire new clients/patients early in pregnancy, provider signup for the SneakPeek Gender DNA Test climbed in 2020 and Q1 2021

Gateway Genomics, leading developer of direct-to-consumer genetic tests that give families insight into their future children, achieved a milestone of over 1,000 distributors of its SneakPeek Clinical test across the US, UK, and Canada. This number represents a doubling of locations since this time last year.

read more

Landmark Large-scale Publication Shows SneakPeek Early Gender DNA Test Predicts Fetal Sex with 99.9% Accuracy, Months Before Ultrasound

In one of the largest clinical studies of its kind, Gateway Genomics' SneakPeek test predicted gender accurately for 1028 of 1029 women between 7-37 weeks into pregnancy.

Gateway Genomics, leading provider of direct-to-consumer genetic tests focused on prenatal and pediatric information, announces a new publication titled, “Large scale follow-up research study: SneakPeek® Early Gender DNA Test 99.9% accurate for fetal sex by live-birth confirmation” in the International Journal of Pregnancy & Child Birth.

read more

Gateway Genomics Launches SneakPeek Early Traits DNA Test that Uses Genetics to Provide a Child’s Features

With this new product, the company that’s known for the SneakPeek Early Gender DNA Test provides a window into what a child will look like as an adult, predicted nutrition levels, and sleep behavior, as predicted by genetics.

Gateway Genomics, leading provider of direct-to-consumer genetic tests focused on prenatal and pediatric information, launches the SneakPeek Early Traits DNA Test for parents of young children to learn more about their unique child. The test offers fun insights on adult physical features as well as helpful tips and advice for predicted nutrition levels and sleep behavior as gleaned from the child’s DNA.

read more